• S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

  • Dec 15 2023
  • Durée: 28 min
  • Podcast

S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

  • Résumé

  • In this episode our faculty take a look at the treatment-related side effects associated with some of the newer treatments for Alzheimer’s disease, with a focus on amyloid-related imaging abnormalities (ARIA). How do you weigh the risk and benefits for your patients?

    Visit www.morningcommutepodcast.com/alzheimers3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

    Voir plus Voir moins

Ce que les auditeurs disent de S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.